Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection
Yongjian Wu, … , Duanman He, Xi Huang
Yongjian Wu, … , Duanman He, Xi Huang
Published September 1, 2021
Citation Information: J Clin Invest. 2021;131(17):e137407. https://doi.org/10.1172/JCI137407.
View: Text | PDF
Research Article Inflammation

TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection

  • Text
  • PDF
Abstract

Triggering receptor expressed on myeloid cells 2 (TREM-2) is a modulator of pattern recognition receptors on innate immune cells that regulates the inflammatory response. However, the role of TREM-2 in in vivo models of infection and inflammation remains controversial. Here, we demonstrated that TREM-2 expression on CD4+ T cells was induced by Mycobacterium tuberculosis infection in both humans and mice and positively associated with T cell activation and an effector memory phenotype. Activation of TREM-2 in CD4+ T cells was dependent on interaction with the putative TREM-2 ligand expressed on DCs. Unlike the observation in myeloid cells that TREM-2 signals through DAP12, in CD4+ T cells, TREM-2 interacted with the CD3ζ-ZAP70 complex as well as with the IFN-γ receptor, leading to STAT1/-4 activation and T-bet transcription. In addition, an infection model using reconstituted Rag2–/– mice (with TREM-2–KO vs. WT cells or TREM-2+ vs. TREM-2–CD4+ T cells) or CD4+ T cell–specific TREM-2 conditional KO mice demonstrated that TREM-2 promoted a Th1-mediated host defense against M. tuberculosis infection. Taken together, these findings reveal a critical role of TREM-2 in evoking proinflammatory Th1 responses that may provide potential therapeutic targets for infectious and inflammatory diseases.

Authors

Yongjian Wu, Minhao Wu, Siqi Ming, Xiaoxia Zhan, Shengfeng Hu, Xingyu Li, Huan Yin, Can Cao, Jiao Liu, Jinai Li, Zhilong Wu, Jie Zhou, Lei Liu, Sitang Gong, Duanman He, Xi Huang

×

Figure 5

TREM-2 interacts with CD3ζ/ZAP70 to enhance TCR signaling.

Options: View larger image (or click on image) Download as PowerPoint
TREM-2 interacts with CD3ζ/ZAP70 to enhance TCR signaling.
(A and B) Nai...
(A and B) Naive CD4+ T cells isolated from WT or TREM-2–/– mice were treated with anti-CD3 mAb (1 μg/mL) for 30 minutes. F4/80+ macrophages treated with LPS (1 μg/mL, 30 min) were used as a control. Cell lysates (input), anti–TREM-2 (A), or anti-CD3ζ immunoprecipitates (B) were analyzed by Western blotting for TREM-2, CD3ζ, and DAP12. (C and D) 293T cells were transfected with a PSG5 vector containing HA-tagged TREM-2, FLAG-tagged CD3ζ, and Myc-tagged ZAP70. Blots of cell lysates (input) or anti-HA (C) and anti-FLAG (D) immunoprecipitates were analyzed by Western blotting for HA, FLAG, and Myc. (E) Human CD4+ T cells or CD11b+ monocytes were sorted from PBMCs from HCs or patients with active TB. Anti–TREM-2 immunoprecipitates were analyzed for CD3ζ and ZAP70. (F) WT versus TREM-2–/– mouse CD4+ T cells were treated with anti-CD3/anti-CD28 Abs (1 μg/mL) and analyzed by Western blotting for CD3ζ (Tyr83) and ZAP70 (Tyr315) phosphorylation. (G and H) PBMCs from patients with active TB (n = 10) were stimulated with anti-CD3/anti-CD28 (1 μg/mL) for 5 minutes. p-CD3ζ (G) and p-ZAP70 (H) in TREM-2+CD4+ versus TREM-2–CD4+ T cells were analyzed by flow cytometry. Data are shown as the MFI of the indicated molecules and represent the mean ± SD from at least 3 independent experiments. ***P < 0.001, by unpaired Student’s t test (G and H). Mϕ, macrophages.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts